Koyfin Home > Directory > Health Care > Acceleron Pharma > Gross Profit

Acceleron Pharma Gross Profit Chart (XLRN)

Acceleron Pharma annual/quarterly Gross Profit from 2012 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Acceleron Pharma Gross Profit for the quarter ending June 06, 2020 was $2m a 2,326.65% increase of 35m year over year
  • Acceleron Pharma Gross Profit for the last 12 months ending June 06, 2020 was $-75m a -29.24% increase of 22m year over year
  • Acceleron Pharma Annual Gross Profit for 2019 was $-80m a -12.44% increase of 10m from 2018
  • Acceleron Pharma Annual Gross Profit for 2018 was $-90m a 15.20% decrease of -14m from 2017
  • Acceleron Pharma Annual Gross Profit for 2017 was $-76m a 51.46% decrease of -39m from 2016
Other Income Statement Metrics:
  • Acceleron Pharma EBITDA for the quarter ending December 12, 2018 was $-36m a 25.58% decrease of -9m year over year
  • Acceleron Pharma Net Income for the quarter ending December 12, 2018 was $-35m a 24.52% decrease of -9m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Gross Profit Data

06/2020$2m
03/2020$-33m
12/2019$-9m
09/2019$-33m
06/2019$-7m
03/2019$-30m
12/2018$-26m
09/2018$-21m
06/2018$-22m
03/2018$-20m

Annual XLRN Gross Profit Data

2019$-80m
2018$-90m
2017$-76m
2016$-37m
2015$-37m
2014$-33m
2013$21m
2012$-20m
2011$47m